Movatterモバイル変換


[0]ホーム

URL:


Prijeđi na sadržaj
Wikipedija
Pretraga

Salicilamid

Izvor: Wikipedija
Salicilamid
Klinički podaci
AHFS/Drugs.comMonografija
Identifikatori
CAS broj65-45-2
ATC kodN02BA55 ,N02BA05
PubChem[1][2]5147
DrugBankDB08797
ChemSpider[3]4963
ChEMBL[4]CHEMBL27577 DaY
Hemijski podaci
FormulaC7H7NO2 
Mol. masa137,136
SMILESeMolekuli &PubHem
InChI
InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)
Key: SKZKKFZAGNVIMN-UHFFFAOYSA-N DaY
Fizički podaci
Tačka topljenja142 °C (288 °F)
Tačka ključanja181.5 °C (359 °F)
Farmakoinformacioni podaci
Trudnoća?
Pravni status

Salicilamid jeorgansko jedinjenje, koje sadrži 7atomaugljenika i imamolekulsku masu od 137,136Da.[5][6]

Osobine

[uredi |uredi kod]
OsobinaVrednost
Broj akceptora vodonika2
Broj donora vodonika2
Broj rotacionih veza1
Particioni koeficijent[7] (ALogP)0,6
Rastvorljivost[8] (logS, log(mol/L))-1,1
Polarna površina[9] (PSA,Å2)63,3

Reference

[uredi |uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  6. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit
  7. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  8. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  9. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

[uredi |uredi kod]

Vanjske veze

[uredi |uredi kod]
Portal Medicina
Portal Hemija
Salicilamid naWikimedijinoj ostavi
Salicilati
Arilalkanoinske kiseline
2-Arilpropionske kiseline
(profeni)
N-Arilantranilne kiseline
(fenaminske kiseline)
Pirazolidinski derivativi
Oksikami
COX-2 inhibitori
Sulfonanilidi
Proizvodi satopičkom primenom
COX-inhibirajući donori azot oksida
Drugi
Podebljani nazivi označavaju jedinjenja (spojeve) inicijalno razvijene u specifičnim grupama.Lekovi povučeni sa tržišta.Veterinarski lekovi.
Izvor:https://sh.wikipedia.org/w/index.php?title=Salicilamid&oldid=42279977
Kategorije:

[8]ページ先頭

©2009-2025 Movatter.jp